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Bayesian inferenceStructural imaging based on MRI is an integral component of the clinical assessment of patients with potential de-
mentia.Wehere propose an individualizedGaussian process-based inference scheme for clinical decision support in
healthy and pathological aging elderly subjects using MRI. The approach aims at quantitative and transparent sup-
port for clinicianswho aim to detect structural abnormalities in patients at risk of Alzheimer's disease or other types
of dementia. Firstly, we introduce a generativemodel incorporating our knowledge about normative decline of local
and global gray matter volume across the brain in elderly. By supposing smooth structural trajectories the models
account for the general course of age-related structural decline as well as late-life accelerated loss. Considering
healthy subjects' demography and global brain parameters as informative about normal brain aging variability af-
fords individualized predictions in single cases. Using Gaussian processmodels as a normative reference, we predict
new subjects' brain scans and quantify the local gray matter abnormalities in terms of Normative Probability Maps
(NPM) and global z-scores. By integrating the observed expectation error and the predictive uncertainty, the local
maps and global scores exploit the advantages of Bayesian inference for clinical decisions and provide a valuable
extension of diagnostic information about pathological aging. We validate the approach in simulated data and
real MRI data. We train the GP framework using 1238 healthy subjects with ages 18–94 years, and predict in 415
independent test subjects diagnosed as healthy controls, Mild Cognitive Impairment and Alzheimer's disease.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Introduction
Magnetic Resonance Imaging (MRI) and computational morphome-
try have become invaluable tools for in-vivo exploration of the underly-
ing changes in healthy and pathological brain aging (Fjell andWalhovd,
2010; Frisoni et al., 2010). Consistent ﬁndings show that regional gray
matter volume, as well as cortical thickness, exhibit substantial decline
as a process of healthy aging (Fjell and Walhovd, 2010; Raz and
Rodrigue, 2006). Importantly, studies observed considerable variability
of age-related structural trajectories across brain regions and healthy
elderly individuals (Raz et al., 2005, 2010; Walhovd et al., 2011). An
open question in clinical practice still is, how to efﬁciently identify
local pathological brain aging in individuals at risk of developingeuroimaging, 12 Queen Square,
ed from theAlzheimer'sDisease
edu/ADNI). As such, the investi-
ementation of ADNI and/or pro-
f this report. Complete listing of
/wp-content/uploads/how_to_
. This is an open access article underAlzheimer's disease (AD) or other types of dementia. Due to the large
individual differences of normative age-related decline, the visual as-
sessment of healthy vs. pathological local atrophy is a challenging task
even for experienced radiologists. While single case studies are long-
standing practice in neuropsychology (for overview of methods see
e.g. Crawford and Garthwaite, 2012; McIntosh and Brooks, 2011),
there is also an increasing number of neuroimaging studies using
Voxel-based Morphometry (VBM) (Ashburner and Friston, 2000;
Mechelli et al., 2005) that focus on single cases in comparison to a
reasonably sized group of control subjects. These studies explored
voxelwise macroanatomy in patients with neurological disorders like
aphasia, Huntington disease, lesions, focal cortical dysplasia, epilepsy,
cortical atrophy, and dementia (Colliot et al., 2006; Maguire et al.,
2010; Mehta et al., 2003; Migliaccio et al., 2012; Mühlau et al., 2009;
Mummery et al., 2000; Salmond et al., 2003; Scarpazza et al., 2013;
Seghier et al., 2008; Sehm et al., 2011; Woermann et al., 1999).
In order to provide statistical measures of suspicious local brain
volumes (or cognitive test scores) in single case studies, several
parametric techniques have been proposed. A simple approach is to
calculate z-scores using the control sample mean and standard devia-
tion. If the observed z-score is found to be less than a certain percentile
of the standard normal distribution, e.g. z b−1.645 (corresponding to athe CC BY license (http://creativecommons.org/licenses/by/3.0/).
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cally signiﬁcant. Unfortunately, the z-score approach lacks the ability
to account for the uncertainty of the control sample statistics, which
might inﬂate type I errors especially in small samples (Crawford and
Howell, 1998). Thus, the more conventional parametric approach to
single case inference is the two sample t-test using a ‘pooled’ estimate
of the variance (for details see e.g. Mühlau et al., 2009). The t-test statis-
tic in the special case with n controls and one single patient reduces to
t ¼ μc−μp
 
= σ c
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1=nþ 1p  with control sample standard deviation
σc. Previous studies explored methodological issues using this type of
unbalanced parametric design. In particular, small samples have been
found to reduce sensitivity for detection of structural differences in
single subjects (Mühlau et al., 2009). Unfortunately, for unbalanced de-
signs the above difference score might be particularly affected by non-
normality, rendering the t-test invalid (Salmond et al., 2002; Viviani
et al., 2007). Robustness of the tests was found to be increased (type I
errors reduced) by using larger smoothing kernels or appropriate trans-
formations of the data. However, for inference in elderly subjects, the
approaches often do not address the underlying developmental process,
e.g. age-related effects in the control sample (see also Dukart et al.,
2011), as well as variations due to other relevant covariates, e.g. global
volume differences (Peelle et al., 2012).
Gaussian process (GP) models have emerged as a ﬂexible and ele-
gant approach for prediction of continuous, i.e. y ∈ ℝ, or binary, i.e. y
∈ [0, 1] variables (Kim and Ghahramani, 2006; Rasmussen, 1996;
Rasmussen and Williams, 2006). Recently,GPs were successfully intro-
duced to the neuroimaging community. The potential applications
range from spatial priors (Groves et al., 2009), cortical maps (Macke
et al., 2011), image denoising (Zhu et al., 2012), parameter estimation
(Wang et al., 2012), white matter ﬁber clustering (Wassermann et al.,
2010) and meta-analysis (Salimi-Khorshidi et al., 2011). GP models
were shown to be particularly powerful for clinical applications, provid-
ing probabilistic predictions of symptom severity, pain states, recovery,
cognitive and disease states using regression (Doyle et al., 2013a; Hope
et al., 2013;Marquand et al., 2010) and classiﬁcation (Hahn et al., 2011;
Marquand et al., 2010; Mourao-Miranda et al., 2012; Pyka et al., 2012;
Young et al., 2013) using functional and structuralMR images as inputs.
In addition to the common application as decoding or recognition
models, i.e. making inference about causes of functional and structural
brain states based on images (Friston et al., 2008), GPs might be partic-
ularly useful for generative modeling of individual differences of brain
morphometry (see also Ashburner and Klöppel, 2011; Friston and
Ashburner, 2004).
Here we propose a new approach to support individualized clinical
decisions about an elderly patient's brain structure by providing quanti-
tative, unbiased and highly transparent maps of local gray matter
abnormalities and global volume z-scores for graymatter, white matter
and cerebrospinal ﬂuid. Thatmeans, themaps and z-scores aim at infor-
mation support rather than providing ﬁxed patient-level predictions
about disease states derived from ‘black-box’ classiﬁers. GPs are used
to implement a normative generative model of elderly subjects' local
and global volumes in terms of a non-parametric function of subjects'
covariates. The model captures normative age-related trajectories and
effects of covariates typically observed in control samples. This implicit-
ly assumes smooth structural trajectories without imposing strong con-
straints on the developmental model and thus allows more ﬂexibility
than low degree polynomial expansions (for discussion of quadratic
ﬁts see e.g. Fjell et al., 2010). At the same time it accounts for region spe-
ciﬁc late life accelerated gray matter shrinkage, which is shown to be
part of healthy brain aging (Fjell et al., 2012, 2013; Walhovd et al.,
2011). The substantial individual differences of local and global volumes
in elderly brains (i.e. even at the same age and ﬁxed covariates) and the
measurement noise are modeled in terms of Gaussian distributions and
accounted for in individualized predictions. Aftermodel optimization in
a large control sample, the local GP priors are conditioned on scans of
new single subjects at risk of developing AD or other types of dementia.Trainingwith a large pooledMRI database of 1238 healthy subjectswith
ages 18–94 years, and testing with an independent sample from the
Alzheimer's Disease Neuroimaging Initiative dataset including subjects
with MCI and AD, we show that the obtained normative probability
maps (NPM) and global z-scores provide a powerful clinical application
by quantitatively characterizing the single patient's abnormalities as
compared to age-matched neurologically normal controls. This imple-
ments a Bayesian single case inference about structural abnormalities
that ﬂexibly accounts for predictive uncertainty in practical situations
of different control data sample sizes, different data noise levels, and in-
dividual patient covariates, i.e. age, brain sizes, etc.
Methods
A Gaussian process model of cross-sectional gray matter observations in
healthy elderly
Ideally, a generative model of the normative structural aging pro-
cess accurately predicts the local gray matter volume y of an elderly
study participant based on the age and a set of informative covariates
x= [age, sex, …],i.e. forming a low dimensional covariate space D∈
ℝm . The predictions require availability of most covariates for all
cases in the training and test samples. Thereby, we here restrict our
local generative model to six covariates summarized in xi =
[age, sex, tgmv, twmv, tcsf, fstr] for subject i, including demography
and global parameters, i.e. total gray matter volume (tgmv), total
white matter volume (twmv), and total cerebrospinal ﬂuid (tcsf)
obtained from MRI preprocessing. Furthermore, for inference about
global atrophy an additional generative model for global brain
parameters tgmv, twmv, and tcsf was applied using four covariates
xi = [age, sex, ticv, fstr] with ticv = tgmv + twmv + tcsf. Note,
the proposed framework also naturally extends to physiological
and behavioral factors, as well as subject independent but scan spe-
ciﬁc variables, e.g. the signal to noise ratio of the scan. In order to af-
ford pooling across samples from 1.5 and 3 Tesla MRI scanners, we
also included a ﬁeld strength variable (fstr). The whole training sample
covariate data is further denoted byX, whichwas obtained from concat-
enation of rows xi for all n training subjects. The rows of brain data ma-
trix Y (with entries yij) refer to theGMV images of all n training subjects,
and yj is used to denote its j-th column, i.e. the data of voxel j from all
subjects. Then the lifespan generative model of gray matter in voxel j
follows
yij ¼ g xi; θ j
 
þ ϵij; ϵij∼N 0;σ2j
 
ð1Þ
with subject index i and hyperparameter θj, an additive independent
identically distributed Gaussian noise (also called the likelihood
model) with variance σj2. The latent (or noise free) variables g(x, θ)
incorporate our knowledge about aging and variability in different loca-
tions x of the covariate spaceD. We now exploit the function space per-
spective and deﬁne a GP prior, which implements our assumption about
smoothness of the latent trajectories g(x, θ). Technically, a GP is a distri-
bution of functions,which is fully speciﬁed by itsmean and its covariance
function (for a technical introduction see Rasmussen and Williams,
2006)
g∼GP m; covð Þ: ð2Þ
The following speciﬁcation of the priormeanm and covariance func-
tion cov implies a distribution over latent structural trajectories and
their individual differences in voxel j
m g xp; θ j
  
¼ 0 ð3Þ
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 
; g xq; θ j
  
¼ kθ j xp ;xqð Þ: ð4ÞThe main idea here is to suppose the covariance of the latent local
and global volumes g(x, θj) to be a function of the similarities among
subjects in covariate spaceD, expressed by a kernel mapping k. How-
ever, because the contribution of eachdimension ofD to latent variables
g is a-priori unknown, we implement the kernel using a squared expo-
nential function with automatic relevance determination (ARD) (Neal,
1996) for each voxel j
kθ j xp;xq
 
¼ ajexp −
1
2
xp−xq
 T
diag ℓ j
 −2
xp−xq
  
; ð5Þ
with covariance hyperparameter θj=(aj,ℓj), i.e. amplitude aj and char-
acteristic length scales ℓj = [ℓ1
( j), …, ℓ6
( j)] corresponding to axes of
space D (similarly with 4 dimensions for global models). In particular,
smaller values of length scaleℓ1
( j) indicate shorter timescales of lifespan
developmental dynamics in voxels j. Intuitively, this parametrization of
the kernel mapping symbolizes that either males or females with simi-
lar ages and global parameters are expected to have similar latent local
gray matter volumes. Using the compact matrix notation the above
model implies the following covariance for observed local gray matter
volumes in voxel j
Cov y j
 
¼ Kθ j þ σ
2
j I; ð6Þ
with yj referring to a column vector of all observations in voxel j, Kθ j ≡
Kθ j X;Xð Þ denoting the evaluated kernel kθ j for all pairs of training
pointsX using the covariance hyperparameters θj, andσj2 again denotes
the noise model variance. A more compact way to introduce the above
model and the Gaussian process prior in Eqs. (1)–(4) using conditionals
is
p y jjg j
 
¼ N g jjσ2j I
 
ð7Þ
p g jjX
 
¼ N 0;Kθ j
 
: ð8Þ
We introduce the marginal likelihood by marginalization over the
latent function values gj using the likelihood p(yj|gj, X) and the prior
p(gj|X)
p y jjX
 
¼ ∫ p y jjg j;X
 
p g jjX
 
dg j: ð9Þ
The logarithm of the GP prior term can be further evaluated
log p g j
 X ¼−1
2
gTjK
−1
θ j g j−
1
2
logjKθ j j−
n
2
log2π: ð10Þ
The integration over Gaussian likelihood and prior can be performed
analytically (for details Rasmussen andWilliams, 2006) and reveals the
log marginal likelihood (or evidence) for the lifespan generative model
of voxel j
log p y j
 X ¼−1
2
yTj
 
Kθ j þ σ
2
j I
!−1
y j−
1
2
logjKθ j þ σ
2
j Ij−
n
2
log2π:
ð11Þ
Model optimization for local and global models is performed
using the conjugate gradient descent of the marginal likelihood,
which is supposed to optimally balance data-ﬁt (term one in
Eq. (11)) and model parsimony (term two). All applications usingGP inference and prediction on MRI data in this paper were per-
formed using Gaussian Process Regression and Classiﬁcation Toolbox
3.4 (GPML, http://www.gaussian-process.-org/gpml/code/matlab/
doc/in-dex.html).
Normative probability maps and global z-scores
The above generative lifespan model of local and global volumes af-
fords individualized predictions for untrained patients at risk of disease
related abnormalities.We denote the optimizedmodel parameterswith
θ^ j and σ^
2
j . The corresponding test sample covariates and brain images
are supposed to be contained in rows ofmatrices X∗ and Y∗ respectively.
For the purpose of predictions in a clinical decision setting, we ﬁrst con-
sider the joint distribution of already observed graymatter values yj and
latent variables of new test subjects gj∗, i.e.
y j
gj
 	
∼N 0;
Kθ^ j
þ σ^2j I Kθ^ j
X;X

 
Kθ^ j
X;X

 
Kθ^ j
X;X

 
2
64
3
75
0
B@
1
CA: ð12Þ
Weobtain the predictive distribution of local graymatter volume for
the patient's latent variables (see also Rasmussen and Williams, 2006)
p

gj jX; y j;X; θ^ j; σ^2j

¼ N

gj ;Cov g

j
 
; with
gj ¼ Kθ^ j
X;X

 h
Kθ^ j
þ σ^2j I
i−1
y j
Cov gj
 
¼ Kθ^ j
X;X

 
−Kθ^ j
X;X

 
Kθ^ j þ σ^
2
j I
i−1
Kθ^ j
X;X

 
:

ð13Þ
By adding the local noise variance σ^2j to the latent predictive vari-
ancewe arrive at the predictive distribution for observed local graymat-
ter in the test sample, given the incorporated knowledge about healthy
structural aging in the training sample
p

yj jX; y j;X; θ^ j; σ^2j

¼ N gj ;Cov gj
 
þ σ^2j I

:

ð14Þ
To implement a Bayesian single case inference, we evaluate the z-
scores of the predictive distribution
δij ¼
yij−g

ij
uij
; ð15Þ
u2ij ¼ kθ^ j
xi ;x

i

 
−kθ^ j
xi ;X

 T Kθ^ j þ σ^2j I
 −1
kθ^ j
xi ;X

 þ σ^2j : ð16Þ
The central ideas are illustrated in Fig. 1. The local z-scores δij of test
subject i at voxel j form the core of the proposed abnormality detection
technique andwill be denotedNormative ProbabilityMaps (NPMs). The
NPMs providewhole brainmaps that reﬂect the probability to observe a
particular patient's value (or even smaller values) of gray matter vol-
ume in a voxel, given the knowledge about structural lifespan develop-
ment incorporated in the above generative model. The global z-scores
were obtained analogous to the local NPMs. Strictly speaking, the
exact probabilitieswould be obtained fromevaluation of the cumulative
predictive distribution. Nevertheless, this integration is expected to pro-
vide skewed distributions and thus might lack simplicity for practical
clinical applications. Alternatively, we deﬁne the NPMs using z-scores,
distributed around zero, with more negative values indicating stronger
atrophy compared to normals and larger positive values showing hy-
pertrophy respectively. The evaluation of local and global z-scores of
the predictive probability densities sets the expected values for δij for
subjects drawn from the training population to zero. This additionally
has the effect of normalizing the expected values across voxels. Note,
Fig. 1. Illustration of the predictive distribution and core elements of the abnormality detectionmethod. (A) The predictive distribution p yjX; y; x; θ^; σ^2Þ

of an arbitrary voxel given the
database covariates, database gray matter volumes, the test subject covariates, the optimized hyperparameters and local noise variance is shown in green. Its mode is the predicted gray
matter volumeg for the test subject. The difference of observed and predicted graymatter volumey−gwedenote prediction error. The spread of the predictive distribution is called the
predictive variance (or uncertainty) u2 (with FW HM∝ u). The core of the method (and entries of NPMs) are abnormality measures δ, the z-scores, i.e. the prediction error in the unit of
standard deviation of the predictive distribution. That is, δ evaluates the prediction error while accounting for differences of predictive uncertainty across subjects and voxels. (B) We il-
lustrate that theNPMs appropriately account for uncertainty differences in all predictions. The prediction errory−g indicates the unexpected atrophy or hypertrophy under the generative
model of normal aging. Then, observing the same prediction error in two subjects (or brain voxels) for instance with fourfold uncertainty (or equivalently twice FWHM) results in half of
the value of δ and thus indicates less severe evidence for abnormality of the test subject.
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i.e. which here denotes the difference of observed and predicted vol-
umes yij−g

ij (and which should not be confused with accuracy), and
the predictive uncertainty uij2, i.e. the variance of the predictive distribu-
tion. Intuitively, the advantage of such a Bayesian modeling approach
for clinical decision support is that two predictions indicating the
same prediction error (in the spirit of yij−g

ij) can also be associated
with very different levels of certainty or conﬁdence (see Fig. 1B).
NPMs and global z-scores account for these conﬁdence differences and
themodel's predictionswill strongly affect our conclusions for low com-
pared to high predictive uncertainty. Inspecting the terms of the uncer-
tainty (Eq. (16)) one can observe that it is increased by the prior
variance and the noise term, and reduced by the information that the
training sample provides about the test case.
Clinical decisions based on NPMs
In contrast to common multivariate decoding schemes in dementia
research (for review see Klöppel et al., 2012), our GP model affords in-
ference about the local and global gray matter volume atrophy, which
is an inference about the consequences rather than the cause, i.e. the
disease status D = [healthy, AD, LewyBody, etc.] (see also Friston and
Ashburner, 2004). However, we aim to show that NPMs and global z-
scores might support the clinical decision process by providing a likeli-
hoodmodel for the implicit inference performed by the clinician. A rea-
sonable inference about underlying disease states Diwould be obtained
by applying Bayes-rule
P Dijscanð Þ ¼
P scanjDið ÞP Dið Þ
P scanð Þ : ð17Þ
If we further make the simplifying assumption of conditional inde-
pendence across voxels denoted with y1,…, yl
P scanjDið Þ ¼ P y1;…; yljDið Þ≈P y1jDið Þ…P yljDið Þ ð18Þ
we arrive at the approximate posterior distribution for disease states
P Dijscanð Þ≈
P Dið Þ
P scanð Þ∏
l
j¼1
P yjjDi
 
: ð19Þ
A clinician following a naive Bayesian inference about the unknown
disease state of an individual with a brain scan (and gray matter vol-
umes y) might implicitly apply mental representation of disease priors
P(Di) (obtained from clinical experience) and the likelihood underdifferent generative models for competing hypotheses P(yj|Di). We
therefore assume that medical expert's decision can be supported by
providing quantitative, valid, and transparent likelihood maps. The
above introduced z-scores provide a measure of the likelihood of ob-
serving yj under the generative model of healthy aging, i.e. P(yj|Di =
healthy), and thus might form a useful reference for all decisions about
alternative disease states.
Application to simulated data
In order to demonstrate the validity and potential of the proposed
GPmodel, we used ground truth simulations followed by an application
to real MRI data. The simulations were designed to emphasize two
major purposes of the model outlined in the following two sections.
Predictions of sparsely sampled individual developmental trajectories
based on subject's covariates
The GP model affords accurate between-subject level predictions
for gray matter observations in samples with large individual differ-
ences and age-related effects. The predictions are made using a set of
subject's covariates, e.g. age, demography, or other brain parameters.
In order to realize simulations we here suppose (A) that gray matter
observations in healthy development and aging essentially stem
from sparse temporal sampling of an ensemble ℰ of individual tra-
jectories and (B) that the considered covariates of interest are phys-
iological or behavioral correlates or contributors to the variability
within the ensemble. We formalize these assumptions by introduc-
ing the following two-level mixed-effects model of the ensemble of
trajectories ℰ. The ﬁrst level model is based on the assumption that
the trajectory of underlying volumetric changes is sampled from
subject speciﬁc functions of age or time
yij ¼ f tij; θ 1ð Þi
 
þ ϵ 1ð Þij ð20Þ
where the measurement yij is the j-th observations obtained from
the i-th subject at time (age) tij, and ϵij
(1) denotes a Gaussianmeasure-
ment error. In particular, we parameterize the trajectory using a qua-
dratic polynomial expansion of age f(tij, θi
(1)) = θ0i + θ1itij + θ2itij2.
This ﬁrst level of the ensemble can be further summarized by y =
X(1)θ(1) + ϵ(1). Although the true individual change parameters θi
(1)
might be unknown, we here suppose to have access to their physio-
logical or behavioral correlates, i.e. subject speciﬁc effects Xc = [x1,
…, xr], e.g. demographic variables, or global brain parameters, etc.
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eters is described by the second level model
θ 1ð Þ ¼ X 2ð Þθ 2ð Þ þ ϵ 2ð Þ ð21Þ
with the parameters θ(2) and design matrix X(2) containing three col-
umns of ones for each θ0i, θ1i and θ2i and further columns for the covar-
iates Xc. Notably, Gaussian noise ϵ(2) adds further random individual
differences to the ensemble of trajectories. The purpose of applying a
nonparametric GPmodel in this context of mixed-effects models of de-
velopment, i.e. assuming f∼GP m; covð Þ, is that it affords predictions for
measures of brain structure yij based on observations of individual co-
variates Xc without knowing the explicit parametrization of trajectory
shape f(t, θ), the information about temporal sampling contained in
X(1), and the structure of the ensemble in design matrix X(2). That
means, GP model optimization corresponds to learning the functional
form of a generative process. Fig. 2A depicts 100 trajectories of the sim-
ulatedhealthy subjects ensemblewith either large (left) or small (right)
individual differences. In order to obtain a typical cross-sectional sam-
ple of local graymatter volumes we assumed a single MRI scan per sub-
ject at random adult lifespan age (see red crosses in Fig. 2A). The
observations yi1 were then modeled as a nonparametric GP function
using subject's age and covariates of individual change parameters x0i,
x1i and x2i as inputs, i.e. corresponding to θ0i, θ1i, and θ2i respectively.
The trained GPmodel allows predictions of observations in an indepen-
dent ensemble of healthy subjects (Fig. 2B). We further varied the
strength of correlation of accessible covariates and ground truth change
parameters corr(xk., θk.) = 0, 0.25, 0.5, 0.75, and 1. As expected, we
found that observing covariates that exhibit stronger relationships toFig. 2. Simulation of structural trajectories, cross-sectional sampling and predictions based on co
…, 640 subjects using the mixed-effects modeling framework described in Eqs. (20) and (21). T
f(tij, θi
(1)) = θ0i+ θ1itij+ θ2itij2 with expectation of change parameters E(θ(1)) = θ(2) = [0.9
= diag([6 ⋅ 10−3, 1 ⋅ 10−6, 2 ⋅ 10−10]) or small individual differences (A right) with Var(θ
indicate cross-sectional observations corresponding to a sparse sampling of trajectories with a
[20, 90]. Observations were performed with additive i.i.d. Gaussian noise with either Var(ϵij(1))
ensembleswere simulated. The second levelmodel (Eq. (21)) also included randomcorrelates/c
of the correlation size to the true change parameter, i.e. corr(xk., θk.) = 0, 0.25, 0.5, 0.75, 1. (B)
covariates xi after training in one ensemble and testing in a second independent ensemble.
corr(x, θ). (C) Mean absolute error of predictions for small and large amounts of noise (ﬁrst lev
ponential covariance (‘SE-GP’) and predicting the same data using the general linearmodel (‘Lin
individual covariates, i.e. [age, x0i, x1i, x2i], indicate improvements in using the Gaussian procesthe ground truth parameters of the mixed-effects generative process,
affords better predictions in the cross-sectional sample. In order to com-
pare the GP based predictions to existing methods, we additionally
computed predictions for the test ensemble using general linear
model (GLM) estimates in the ensemble used for training. Fig. 2C de-
picts mean absolute error of predictions in an independent test ensem-
ble based on squared exponential covariance GP and GLM. Predictive
performance was compared using either only subject's age or age to-
gether with three covariates x0i, x1i and x2i. We independently varied
the total amount of individual differences in terms of the second level
error in the ensemble and the amount of noise in terms of the ﬁrst
level error. The obtained simulation for nonlinear trajectories suggests
the advantages of GP based compared to GLM based predictions for dif-
ferent contexts of developmental data.
Inference about local gray matter volume abnormalities in pathological
aging trajectories
We further explored the potential of GP based inference about
gray matter abnormalities in pathological aging. Having captured
the large age-related variance and further individual differences in
a healthy sample of brain development and aging, we here aim at
evaluating the likelihood of unseen test subjects' brain scans given
the database as a normative reference. We therefore simulated an
ensemble of trajectories from diseased subjects ℰd by assuming a
substantial additive linear disease process beginning at a random age
of onset θ4i : f(tij, θi
(1)) = θ0i + θ1itij + θ2itij2 + θ3i ⋅ max([0, tij− θ4j]).
With exception of this disease process, this parametrization of the tra-
jectories is assumed to be identical to the ensemble of healthy subjectsrrelates of individual change parameters. (A) Illustration of simulation of data yi1 for i=1,
wo random ensembles of individual trajectories using a quadratic model parametrization
2, 4 ⋅ 10−3, 1 ⋅ 10−4] and either large individual differences (A left) with Var(θ(1))
(1)) = diag([6 ⋅ 10−4, 1 ⋅ 10−7, 2 ⋅ 10−11]). Only 100 trajectories are shown. Red crosses
single MRI observation per subject i at age ti1 distributed uniformly over the adult lifespan
= 0.01 (large noise) or 6 ⋅ 10−6 (small noise) respectively. Independent training and test
ovariates xi=[x0i, x1i, x2i] of ground truth individual change parameters θi under variation
Gaussian process based predictions (using Eq. (14)) of observations yi1 based on subject
Rows illustrate the increase of precision of predictions under different correlation sizes
el error) and individual differences (second level error) for a GP model with squared ex-
ear’) estimated in the training data. Both, predictions using only subject's age and using all
s model for different types of data.
Fig. 3. Simulation of an ensemble of structural trajectories with additive disease pro-
cess and comparison of methods for their detection in an ensemble of healthy trajec-
tories. (A) Illustration of simulations of observations yi1 for i = 1, …, 640 from
diseased subjects using the mixed-effects modeling framework described in
Eqs. (20) and (21). The random ensemble of individual trajectories followed the
healthy subject quadratic model with additional linear decline after individual age
of onset at age θ4i: f(tij, θi
(1)) = θ0i+ θ1itij+ θ2itij2 + θ3i ⋅max([0, tij− θ4j]) with expec-
tation of change parameters E(θ(1)) = θ(2) = [0.92, 4 ⋅ 10−3, 1 ⋅ 10−4,−0.02, 65] and
individual differences deﬁned by Var(θ(1)) = diag[([6 ⋅ 10−3, 1 ⋅ 10−6, 2 ⋅ 10−10,
1 ⋅ 10−4, 20])]. Only 100 trajectories are shown. Red crosses indicate cross-sectional
observations similar to the healthy ensemble. Observations were performed with ad-
ditive i.i.d. Gaussian noise with noise Var(ϵij
(1)) = 2 ⋅ 10−5. (B) Comparison of differ-
ent statistics for detection of increased atrophy in 640 healthy and 640 diseased test
subjects using single case inference based on an independent healthy control sample.
T-values t ¼ μc−μp
 
= σ c
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1=nþ 1p  (see Introduction) are depicted in red over in-
dividual time of onset of disease. T-test after correction for age-effects in control
and test sample is shown in blue. Proposed Gaussian process based z-scores
(Eq. (15)) are shown in green. GP training is performed on an independent healthy
ensemble of trajectories. Rows show different correlation sizes of the covariates
(used for prediction with GP) with the true change parameter.
2 Data used in the preparation of this article were obtained from the Alzheimer's Dis-
ease Neuroimaging Initiative (ADNI) database (adni.loni.ucla.edu). The ADNI was
launched in 2003 by the National Institute on Aging (NIA), the National Institute of Bio-
medical Imaging and Bioengineering (NIBIB), the Food and Drug Administration (FDA),
private pharmaceutical companies and non-proﬁt organizations, as a $60 million, 5-year
public–private partnership. The primary goal of ADNI has been to test whether serial mag-
netic resonance imaging (MRI), positron emission tomography (PET), other biological
markers, and clinical and neuropsychological assessment can be combined to measure
the progression of mild cognitive impairment (MCI) and early AD. Determination of sen-
sitive and speciﬁc markers of very early AD progression is intended to aid researchers
and clinicians to develop new treatments andmonitor their effectiveness, aswell as lessen
the time and cost of clinical trials. The Principal Investigator of this initiative is MichaelW.
Weiner, MD, VAMedical Center and University of California-San Francisco. ADNI is the re-
sult of efforts of many co-investigators from a broad range of academic institutions and
private corporations, and subjects have been recruited from over 50 sites across the U.S.
and Canada. The initial goal of ADNI was to recruit 800 adults, ages 55 to 90, to participate
in the research, approximately 200 cognitively normal older individuals to be followed for
3 years, 400peoplewithMCI to be followed for 3 years and200 peoplewith early AD to be
followed for 2 years. For up-to-date information, see www.adni-info.org.
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random age of MRI acquisition. In this context of mixed-effects models
for development and aging, early disease detection corresponds to clas-
sifying new subjects based on a single observation into ensembles ℰ
and ℰd respectively. As a proof of principle, we here compared the
GP-based z-scores and t-values with respect to their ability to detect
the abnormality of diseased subjects after the age of onset. Fig. 3B com-
pares z-scores, and t-values, and t-values with correction of age effects
in the control and test sample as a function of years relative to the indi-
vidual onset of disease. We found that all considered indices exhibit
comparable values before the age of onset. However, after disease
onset the z-scores showed a steeper declinewith years after onset com-
pared to t-tests. This indicates an increased sensitivity for early diseasedetection, in particular using more informative covariates with higher
correlation to the ground truth individual differences of the generative
process. Based on the above assumptions, this ﬁnding indicates the po-
tential of using informed predictions to access deviations from normal-
ity in real MRI data applications.
Application to real MRI data
Database
The GP models of normative aging were trained using a large
cross-sectional healthy aging brain database, which has been pooled
using healthy controls' T1-weighted MRI scans from four freely
available multi-center samples. Firstly, we included 116 healthy con-
trols' (ages 60–90 years, mean age 75.9 years) baseline/screening
scans from the ADNI1 dataset of the Alzheimer's Disease Neuroimag-
ing Initiative (ADNI, http://www.adni-info.org)2 (see also Mueller
et al., 2005). Secondly, 316 healthy controls (ages 18–94, mean age
45.1 years) from the cross-sectional release of the Open Access Se-
ries of Imaging Studies (OASIS, http://www.oasis-brains.org) en-
tered the database (Marcus et al., 2007). Thirdly, 561 subjects
(19–85 years, mean age 48.0 years) from the IXI database (http://
biomedic.doc.ic.ac.-uk/brain-development) were included. Finally,
245 participants (19–85 years, mean age 44.5 years) from the Inter-
national Neuroimaging Data-sharing Initiative (INDI, http://fcon_
1000.projects.nitric.ord/indi/indi_ack.html) Functional Connectome
Project/INDI imaging sites Atlanta, Baltimore, Berlin, Cambridge,
ICBM, Leiden, Milwaukee, Muenchen, and New-York entered the
training sample (for additional information see Mennes et al.,
2013). The sample selection of healthy elderly subjects was per-
formed in order to realize a sufﬁcient coverage of the adult lifespan
age range. Apart from the chronological age, we did not apply any
additional phenotypic information-based inclusion criteria. After ex-
cluding subjects with artifacts or errors during the MRI preprocess-
ing steps (see section below) and pooling the subsamples we
obtained the ﬁnal VBM database for subsequent GP model training
(n = 1238, 686/552 female/male, ages 18–94 years, mean 49.7, std
19.7). Notably, 245 subjects from the INDI sample and 180 subjects
from the IXI sample were scanned with 3 Tesla scanners, while all
other subjects in training and testing were scanned with 1.5 Tesla
scanners. The differences due to variations of scanner ﬁeld strength
were explicitly accounted for in the subsequent modeling steps.
The database samples densely over the adult lifespan containing
288/175/164/190/169/188/64 subjects with ages 18–30, 31–40,
41–50, 51–60, 61–70, 71–80, and 81–94 years respectively. Further-
more, we chose a large subsample of the ADNI1 database with T1-
weighted scans of 415 study participants with ages 55–93 years to
detect local brain abnormalities. This independent test sample
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agnosis of MCI during the whole ADNI study (sMCI), 92 converting
from original MCI diagnosis at baseline to AD during the ADNI
study (pMCI), and 128 scans of patients diagnosed with AD. Note,
that we chose random non-overlapping subsamples of the ADNI
healthy subjects for training and testing. This affords valid testing
of the generalization capability of our approach.
Image preprocessing
A detailed overview of the acquisition protocols can be found on
the corresponding project references. From the available samples
we included T1-weighted images with a maximum voxel dimension
of 1.5 mm. All further preprocessing steps were performed inSPM8
(Wellcome Trust Centre for Neuroimaging, London, UK, http://
www.ﬁl.ion.ucl.ac.uk/spm) using the VBM8 toolbox (http://dbm.
neu-ro.uni-jena.e/vbm). During preprocessing all images were inter-
polated to an isotropic resolution of 1.5 mm. The images were (1)
corrected for bias-ﬁeld inhomogeneities, (2) registered using a line-
ar (i.e. 12-parameter afﬁne) and a nonlinear diffeomorphic transfor-
mation (Ashburner, 2007), and (3) stripped of non-brain tissue in
the T1-weighted images. Thereafter, some results from the SPM8
uniﬁed segmentation package (Ashburner and Friston, 2005) were
used to initialize a VBM8 algorithm that classiﬁes brain tissue into
gray matter (GM), white matter (WM), and cerebrospinal ﬂuid (CSF).
In order to avoid introducing a systematic bias into the segmentation
of adult and elderly subjects' brains the applied segmentation is prior
free. The VBM8 segmentation contains partial volume estimation
(PVE) to account for mixed voxels with two tissue types (Tohka et al.,
2004). The algorithm uses an adaptive maximum a posteriori (AMAP)
approach (Rajapakse et al., 1997) and a subsequent application of a hid-
denMarkov random ﬁeldmodel (Cuadra et al., 2005).Within the AMAP
estimation, the local variations of the parameters (means and variance)
aremodeled as slowly varying spatial functions. This accounts for inten-
sity inhomogeneities and other local variations. We further quality
checked the database using covariance-based inhomogeneity measures
of the sample as implemented in the VBM8 toolbox. Thereafter, the
resulting gray matter volume images were multiplied voxelwise by
the determinants of Jacobian matrices from SPM's nonlinear transfor-
mations. This modulation is done to adjust for local volume changes in-
troduced by the nonlinear normalization. Finally, in order to explore the
effects of different degrees of smoothing we reran all GP models using
Gaussian kernels of 4, 8, and 12 mm full width at half maximum
(FWHM) respectively. The imagesweremasked by a binary image indi-
cating voxelwise sample mean of gray matter volume exceeding abso-
lute threshold of 0.05. All GP modeling steps were performed on
subsamples of database images obtained using the above steps. To re-
duce computational expense the local GP optimization and predictive
map predictions were performed in a downsampled 3 mm grid obtain-
ed from the 7th degree B-spline interpolation. The obtained 52,252 gray
matter voxels from1238 subjectswere assumed to reﬂect aging-related
differences, as well as normative individual variability in terms of ﬁne-
grained maps of local gray matter volume (GMV) content.
Transformation of the data
Recent work on Voxel-based Morphometry methods has explored
conditions, under which parametric tests may reveal invalid conclu-
sions (Viviani et al., 2007). In particular, the authors showed that severe
departures from normality of local gray matter volume distributions
may affect signiﬁcance thresholds, especially for highly unbalanced de-
signs. Although classical frequentist andBayesian inference schemes are
fundamentally different, similar violations of the normality assumptions
might introduce biases in our model estimates. As suggested by Viviani
et al. (2007), applying heterogeneous voxel-by-voxel transformations
might reduce non-normality and its consequences. We follow a similarapproach by entering the preprocessed data to a voxelwise Box–Cox
power transformation (Box and Cox, 1964) of the following form
f λ yð Þ ¼
yλ−1
λ
log yð Þ
if λ≠0
if λ ¼ 0:
8<
: ð22Þ
The local parameter λ for each voxel was chosen bymaximization of
the log-likelihood function
L λð Þ ¼−n
2
logσ2λ þ log Jλ; ð23Þ
with the number of training samples n, the estimated residual vari-
ance σλ2 under the maximum likelihood ﬁt of the transformed data,
and the Jacobian of the transformed data Jλ. In order to preserve
the voxelwise scaling of the transformed data for further modeling
steps, we normalized the transformed data according to fλ. Due to the
nonlinearity of mapping fλ approximate normalization can be achieved
using linear Taylor expansion around the mean μ, i.e. fλ(y)≈ fλ(μ) +
fλ′(μ)(y− μ), from which follows that Var(y)≈ Var( fλ(y)/fλ′(μ)). Note,
the local data transformation is a separate modeling step performed
before subsequent GP modeling steps. This local parameter λ was
determined using only the training database and further reused to
transform the testing sample images in a similar way.
Results
In order to demonstrate the validity of the proposed GP framework
for local and global abnormality detection in neuroimaging data,
we trained the above speciﬁed models using the large healthy sub-
ject database. The noise variance captures the remaining variance
in the observations unexplained by variability in covariate space.
Fig. 4A depicts the obtained spatial pattern of the noise from data
smoothed with a Gaussian kernel of 8 mm FWHM. With the excep-
tion of the thalamus, most cortical graymatter regions exhibited rea-
sonably small noise variance. At the same time the evidence closely
resembled the spatial pattern of the noise term, with higher evidence
in regions with less unexplained variance in observations (Fig. 4B,
left). Increased spatial smoothness in the observations reduced the
local amount of noise and increased the model evidence. At least in
part, this might be related to regional variance differences of modu-
lated local gray matter volume after between-subject normalization
(Fig. 4B right plot). Histograms of whole brain voxelwise character-
istic length scales are shown in Fig. 4C. The proposed model is sym-
metric with respect to the dimensions of the covariate space and a
projection on the age dimension reveals adult lifespan local structur-
al trajectories (Fig. 4D).
An assumption that affords computationally tractable and efﬁcient
local GP model inference is the Gaussianity of the noise model. More-
over, any violations of Gaussianitymight result in biased single case pre-
dictions and inference. As suggested by Ashburner and Friston (2000)
the quantile–quantile (Q–Q) plot might provide a normality statistic
for the model residuals. The Q–Q plots sample quantile versus the sam-
ple quantile that would be expected if the residuals were normally dis-
tributed. If so, a Q–Qplotwould result in a straight line. A deviation from
a straight line can be identiﬁed by calculating the correlation coefﬁcient
of the Q–Q plot. The expected and observed Q–Q plot correlation coefﬁ-
cients for our database are shown in Fig. 5A (left). The correlationswere
mainly observed in the interval [0.99, 1] but nevertheless exhibited
slight deviations from the theoretical expectation under normality.
We explored these deviations by calculating the third and fourth stan-
dardized moments of residuals, i.e. skewness and kurtosis respectively.
As expected formodulated graymatter volume data, the residuals show
a slightly positive skewness for many voxels (see Fig. 5A middle). Addi-
tionally, but less emphasized, kurtosis was found to be slightly higher
than three indicating a more peaky distribution with heavier tails (see
340 G. Ziegler et al. / NeuroImage 97 (2014) 333–348Fig. 5A right). Application of larger smoothing kernel sizes improved
normality but left a noticeable positively skewed distribution of obser-
vations, even with large smoothing kernels. As recently suggested by
Viviani et al. (2007) we explored the beneﬁts of local Box–Cox transfor-
mation of the gray matter volume observations before subsequent GP
modeling. Fig. 5B depicts Q–Q plot correlations and standardized mo-
ments of the model residuals after the transformation. Applying Box–
Cox transform to the data substantially improved the Gaussianity by re-
ducing residuals' skewness toward the expectations under normality
assumptions.
Fig. 6 illustrates the single hippocampus voxel (at 24, −12, −18
MNI) local model (top row) and the three global models (bottom
row) for each tissue class. In order to afford visualization, we only
show the dependency on age and global parameters (top row) and
on age and total intracranial volume (bottom row) using 3D surface
plots. Models of local and global brain parameters indicate that GPs are
able to capture nonlinear dependencies in the data. The core of GP
model is the full posterior distribution of predictive latent variables,
which also provides an uncertainty for all locations in the input space.
Notably, we observed a profound effect of variation of training sample
size that indicated an increased predictive latent uncertainty in sparsely
sampled locations of the covariate space in smaller samples, e.g.
inspecting very old people, very large brains etc. We further aimed at
prediction of local gray matter volume in the independent ADNI test
sample of 100 healthy subjects. Fig. 7A shows the mean absolute error
(MAE) of local predictions using GPs (left) in direct comparison to the
general linear model (right). The MAE was found to be smaller using
the GP model, especially in temporal and medial temporal lobe gray
matter regions. In addition to the prediction error, an integral part of
the proposed method is the predictive uncertainty. Thus, we also ex-
plored the effects of training sample size and data smoothness on pre-
dictive uncertainty. We found that the average uncertainty in test
samplewas rather independent of sample size, and that image smooth-
ness induced noise differences had stronger effects (see Fig. 7B left).Fig. 4. Gaussian process generativemodel of local graymatter volume using 1238 healthy adult
for data after smoothingwith 8mmGaussian kernel is shown. The noise term captures unexplai
local noise variance, respectively. (B) Shown is the relationship of localmodel evidence and the
particular, by applying Gaussian kernels of 4 (red), 8 (blue), and 12 (green) mm FWHM. Additi
evidence and the standard deviation of gray matter volume observations (log log plot) across
length scale parameters l1
( j) of the input variables obtained from model optimization. (D) 1
model. Shown is g(x, θj) as a function of subject's age.However, the predictive uncertainty for single case decisions strongly
varied across subjects in the test sample when training GP models
with smaller control samples (see Fig. 7B right).
In order to validate the GP-based z-scores for single case inference in
subjects with dementia, we also assessed global and local z-scores (i.e.
NPMs) in subjects with clinical indications for neuropathology, in par-
ticular with diagnosis of Mild Cognitive Impairment and Alzheimer's
disease. Fig. 8A shows ADNI test sample z-scores for local gray matter
volume in the hippocampus voxel (24, −12, −18 MNI) and global
brain volumes after GP model training with the full healthy aging data-
base. The average z-scores across the healthy controls were found to be
close to zero. In contrast, clinical group subjects' revealed decreased z-
scores in hippocampus voxel volume and total gray matter volume
and increased z-scores of total cerebrospinal ﬂuid volume. Irrespective
of the substantial variability in healthy aging, the z-scores of test
patient's suggest additional local hippocampus and global gray matter
volume atrophy. Assuming that the diagnosis of the ADNI subjects is
true, one can compare the efﬁciency of local and global z-scores with
the conventional approach of t-test based single case inference. For
the particular purpose of comparison we applied Gaussian process clas-
siﬁcation to separate patients with pMCI and AD from controls only on
the basis of the hippocampus voxel and the global volumes (Fig. 8B,
see also Discussion). Fig. 8B middle column shows the receiver operat-
ing characteristic (ROC) curves and the area under curve (AUC) as per-
formance metrics for the two dimensional classiﬁcation using z-scores
from hippocampus gray matter volume and one of the global brain pa-
rameters. Using local and global z-scores combined revealed a better
classiﬁcation performance in termsof AUC compared to the convention-
al t-value based separation on a subject by subject basis (Fig. 8B right
column). Finally, in order to illustrate the proposed method, Fig. 9 sum-
marizes model components and NPMs in 6 ADNI test subjects. De-
creased z-scores are expected to emphasize local gray matter
abnormalities due to atrophy or alternatively unknown covariate ef-
fects. Focal reductions of predictive probabilities were particularlysubjects with ages 18–94 years. (A) The estimated local noise term log σ^ð Þ of the GPmodel
ned variability of graymatter volume observations. Red and blue indicate larger vs. smaller
noise term log σ^ð Þ (log log plot) across all voxels for different degrees of smoothing (left). In
onally histograms of the corresponding indices are shown. The relationship of local model
all voxels is shown for different degrees of smoothing (right). (C) Histogram of voxelwise
00 random voxel lifespan gray matter volume trajectories of the estimated generative
Fig. 5.Gaussianity of the residuals under the generativemodel of local graymatter volume using 1238 healthy adult subjects with ages 18–94 years and different degrees of smoothing, in
particular applyingGaussian kernels of 4 (red),8 (blue), and 12 (green)mm fullwidth at halfmaximum(FWHM). Expected results underGaussian assumptions are given in black. Top row
shows residuals from untransformed data whereas the bottom row depicts voxelwise Box–Cox transformed data. (left) Histogram of Q–Q plot correlations of all voxels. (middle) Histo-
gram of voxelwise sample estimates of skewness. (right) Histogram of voxelwise sample estimates of kurtosis.
341G. Ziegler et al. / NeuroImage 97 (2014) 333–348observed in lateral and medial temporal lobe regions of many patients
diagnosed with AD.
Discussion
Here we applied Gaussian process models for prediction and single
case inference about local and global brain structural abnormalities in
aging subjects. We implemented a non-parametric generative model
of healthy aging, which allows individualized predictions in patients at
risk of developing dementia. Using simulations we demonstrated ad-
vantages of the approach over existing methods for the purpose of pre-
diction and inference in healthy and diseased subjects. As a further
proof of concept, we focussed on real MRI data in a large healthy aging
VBM database and tested the GP models to detect abnormalities in the
most common neurodegenerative disease, AD. An accumulating body
of work has demonstrated that medial temporal lobe atrophy is a con-
sistent and pathologically veriﬁed (Burton et al., 2008) marker for AD
(for review see Frisoni et al., 2010) which also has been shown to
have the strongest effect sizes in direct comparison of controls and AD
(Risacher et al., 2010). Medial temporal atrophy is also one of the MR-
based biomarkers discussed for revised deﬁnitions of AD (Dubois
et al., 2010; McKhann et al., 2011). Applying our GP model to the test
samples, we observed a considerable reduction of medial temporal
lobe z-scores in patients diagnosed with MCI and AD.
As suggested by related studies using parametric models (Salmond
et al., 2002; Scarpazza et al., 2013), we aimed at reducing potential
biases due to violations of normality assumptions of modulated VBM
data. As shown by Viviani et al. (2007), inﬂuences of non-normality
can be successfully reduced by appropriate transformation of the data.
Crucially, the deviations fromnormality do not follow a uniform pattern
across voxels, and thuswe applied a voxel speciﬁc Box–Cox transforma-
tion using a maximum likelihood method. By doing so, we observed a
substantial improvement of residuals' normality, which was further in-
creased by precedent application of 8 mm or 12 mm Gaussiansmoothing kernels. We found that the local GP model evidence was
strongly dominated by the variance of noisemodel, i.e. with lower resid-
ual variance resulting in higher evidence. Note, however that the ob-
served evidence differences do not have the same meaning as in the
context of Bayesian model comparisons (see e.g. Penny, 2012) where
one compares different models of the same data rather than different
models of different data, e.g. from different voxels. Most cortical re-
gions provided slightly smaller noise variances compared to subcor-
tical regions especially the thalamus and also the basal ganglia. These
regional differences in the GP models might be due to effects of seg-
mentation, nonlinear normalization, the total explained variance by
the covariate space, and the true individual differences of local gray
matter volume. There was a further tendency to a slightly smaller
amount of noise in fronto-temporal compared to occipito-parietal
gray matter regions which might be related to the fact that
age-related effects in elderly subject brains are often found to be
less emphasized in posterior brain regions (Fjell and Walhovd,
2010; Raz and Rodrigue, 2006).
Earlier studies demonstrated that VBM and parametric models
afford inference about age-related gray matter volume differences in
healthy aging groups (Good et al., 2001; Hutton et al., 2009; Kennedy
et al., 2009; Ziegler et al., 2012b) and brain pathology in single patients
(Colliot et al., 2006; Mehta et al., 2003; Mühlau et al., 2009; Salmond
et al., 2003; Sehm et al., 2011). In addition, recent studies also showed
the potential of recognition models and multivariate classiﬁers to de-
code early stage diagnosis based on brain scans in dementia and espe-
cially AD (Adaszewski et al., 2013; Davatzikos et al., 2009, 2011;
Klöppel et al., 2008; Misra et al., 2009; Westman et al., 2011, 2012). Al-
thoughmultivariate decodingmodels are expected to be powerful, sen-
sitive, and highly accurate, we argue that using only ‘black box’ schemes
might lack transparency and simplicity for decisions made in current
clinical practice. Therefore, our approach aimed at decision support in
the gap betweenmultivariate classiﬁers (Klöppel et al., 2008) and qual-
itative visual inspection of scans (DeCarli et al., 2007; Korf et al., 2004).
Fig. 6. Gaussian process models of local and global graymatter volume in the 1238 healthy subject sample. (A) Illustrates the GP based generative model of local GMV in a single voxel in
hippocampus (24,−12,−18) mmMNI. Columns indicate the dependency on age and total gray matter volume (tgmv, left) total white matter volume (twmv, middle) and total cere-
brospinal ﬂuid volume (tcsf, right) respectively. Depicted are 3D surface plots of model components, continuously shown over test locations in input dimensions. Posterior distribution
of latent variables g x; θ^
 
with expectation g (red) and standard deviation g  1:96std gð Þ (green) is shown. The likelihood model standard deviations σ= std(ϵ) is shown at g  1:96
σ (gray). (B) Illustrates the GP based generative model of tgmv (left), twmv (middle) and tcsf (right). Columns indicate total intracranial volume (ticv) and age respectively.
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corporates model- and predictive uncertainty for the single case infer-
ence. As recently emphasized by Klöppel et al. (2012), furnishing
predictive probabilities in clinical disease state classiﬁcation tasks can
provide useful measures of the conﬁdence for classiﬁcation results.
This idea was also explored byMarquand et al. (2010) using GP classiﬁ-
cation of whole brain patterns of brain activity in response to thermal
pain (see also Hahn et al., 2011). We extend these results to GP regres-
sion of continuous variables and show the potential value of predictive
probabilities to support clinician's decisions about gray matter abnor-
malities in aging subjects.We like to point out two interpretations. First-
ly, the presented z-scores from the local NPMs and global indices aim to
support clinical inference about single patients' brain structure at risk of
dementia. In analogy to neuropsychological test scores, by inspecting
the NPM and the three global z-scores of a patient, the clinician is quan-
titatively and transparently informed about the patient's brain volumes
in relation to a large healthy reference sample. At the same time the ap-
proach accounts for the effects of important covariates and individual
differences aging. Increasingly negative z-scores indicate an increased
risk of local and global atrophy. Secondly, NPMs can be seen as part of
a naive Bayesian inference, which clinical experts might follow when
judging scans about alternative causes of atrophy in an individual pa-
tient at risk of developing dementia. Thus, to support inference about
several causes, the NPMs of P(scan|healthy) might be complemented
by speciﬁc disease likelihood maps, e.g. P(scan|AD) for Alzheimer's dis-
ease. The latter could be similarly obtained from local GP based pathol-
ogy models in the clinical populations of interest.
As recently pointed out,multivariate recognition of ADdisease states
(Dukart et al., 2011) and voxelwise generative models of AD diseaseprogression (Dukart et al., 2013) should necessarily account for region-
ally inhomogeneous age-related baseline changes in healthy controls.
Thus, considering this variability our trajectory model presents an ap-
propriate reference for detection of gray matter abnormalities in early
and late disease onset, e.g. in early-onset vs. late-onset AD. Moreover,
it extends existing approaches by avoiding the limitations of low degree
polynomial expansions of age (see also Fjell et al., 2010). The shape of
lower degree models is restrictive and imposes strong constraints on
the unknown developmental process. This might reveal poor estimates
of the structural trajectory in analyses spanning several decades of the
lifespan. Although higher degree polynomials provide more ﬂexibility
of trajectory shape than lower degree polynomials, for our purpose of
predictions we prefer a non-parametric GP covariance model which
does not require additional model comparisons for the selection of dif-
ferent polynomial degrees. Note, that using a GPmodel has some formal
correspondence to regularization problems using penalties on deriva-
tives and also smoothing spline models (Wahba, 1990) can be seen as
a special case of the GP framework (see e.g. Sections 6.2 and 6.3 in
Rasmussen and Williams, 2006). In contrast to recent applications of
smoothing splines and kernel estimators in structural neuroimaging,
the GP framework applies Bayesian evidence based optimization of
length scale parameters instead of using cross-validation procedures
to specify the smoothness or kernel bandwidth parameters respectively.
Note, that unlike polynomial models, a squared exponential GP covari-
ance implements a local regression method, i.e. the local structural tra-
jectory only depends on data points of subjects with similar ages. This is
particularly useful for lifespan studies, where additional inclusion of
older (younger) subjects might not be expected to change predictions
for younger (older) participants respectively. Our approach has some
Fig. 7.Gaussian process model predictions in independent ADNI test sample of healthy subjects. (A) Mean absolute error of local predictions using squared exponential GP (left)
based on subject's age, sex, global volumes, and type of scanner as input variables. For method comparison the predictions were repeated using the general linear model (GLM)
estimates B=(X′ ∗ X)−1X′ ∗ Y of the all covariates X in the training sample for predictions Yt= Xt ∗ B in the test sample. (B) Exploring the effects of training sample size on the predictive
variance (uncertainty) uij2 for predictions of hippocampal GMV at (24,−12,−18) of the independent ADNI test sample. Random training subsamples of sizes 40, 80, 160, 320, 640 and
1238were drawn andGaussian kernels of 4 (red), 8 (blue), and 12 (green)mm fullwidth at halfmaximum(FWHM)were applied. The local GPmodel optimization and ADNI healthy test
sample predictions were repeated 20 times and the following parameters were averaged across these repetitions. The plots show the mean (left) and standard deviation (right) of the
predictive uncertainty in the test sample. Increasing the training sample size mainly reduces the subject by subject variability of individual predictive uncertainty of the model.
343G. Ziegler et al. / NeuroImage 97 (2014) 333–348similarity to outlier detections schemes, used for patient classiﬁcation.
In a recent study Mourao-Miranda et al. (2011) addressed the problem
of measuring departures from a distribution of Gaussian multivariate
patterns of fMRI activity by modeling the boundary of this distribution.
It is important to note thatwe aimed to provide amap to support ex-
pert decisions about the current state of atrophy rather than to predict
the subject's disease status per se. In contrast,we here address inference
at the level of local and global gray matter volumes. The above present-
ed classiﬁcation of subjects based on local and global volumes was used
to provide a proof of principle that GP z-scores might afford slightly
more accurate characterization of individuals compared to existing
methods. Otherwise, for the purpose of inference about the causes of at-
rophy, e.g. AD vs. MCI, AD vs. NO, etc., the whole pattern of features
combining theNPMand global z-scores is expected to bemore informa-
tive than single voxels and can be feed into supervised learning algo-
rithms. We would also like to mention the commonalities and
differences with the BrainAGE approachwhichwas recently introduced
by Franke et al. (2010). The author's multivariate age decoding scheme
has shown potential applications for accurate predictions of conversion
of MCI to AD (Gaser et al., 2013). Both models, BrainAGE and NPMs ex-
ploit prediction errors under the assumption of amodel of healthy brain
aging and take advantage of the increased availability of healthy subject
MRI data. However, the approaches also fundamentally differ with re-
spect to the level of inference and treatment of individual differences.BrainAGE provides a whole brain pattern-based index of age-typical at-
rophy, whereas NPMs quantify normative expectation and conﬁdence
about local gray matter volumes. We therefore argue, that both ap-
proaches provide complementary and potentially useful information
about a single elderly patient's brain. In contrast to the application of
multivariate classiﬁers (for review Klöppel et al., 2012) the integration
of likelihood and priors is still performed by a clinician himself. The ben-
eﬁt of this approach though can only be veriﬁed in clinical settings using
this technique in direct comparison with visual inspection of structural
MRI scans in native space. Notably, native space T1 scan inspection pro-
vides qualitative in contrast to quantitative information about the atro-
phy in single cases. Moreover, the prior knowledge accumulated over
years of clinical experience is still expected to reﬂect smaller sample
sizes than the1238 subjects. However, at themomentwe can only spec-
ulate that clinicians who additionally inspect the quantitative model
based NPMs and three global z-scoresmight come tomore valid clinical
conclusions facing patients with different brain sizes, sex, and up to ﬁve
decades of age differences. Further validation studies might address the
comparison of qualitative and quantitative single case inference
schemes in clinical settings.
In order to facilitate applications in other samples, we explored the
effects of image smoothness and sample size for our GPmodel and indi-
vidualized predictions, especially the predictive uncertainty. Using large
smoothing kernels for VBM data, a higher validity of statistical tests is
Fig. 8.Gaussian processmodel based z-scores of global and local volumes in theADNI test sample. (A) First column shows z-scores of predictive probabilities δij of hippocampal voxel GMV
at (24,−12,−18) mmMNI of 415 scans from study participants with ages 55–93 years. Separate boxplots for 100 NO, 95 stable MCI (sMCI), 92 progressive MCI (pMCI), and 128 AD
subjects subgroups are shown. Columns 2–4 depict z-scores for the GP model of global volumes. (B) Potential of GP-based local and global volume z-scores and comparison to t-test
based single case inference. The left column shows a characterization of the pMCI and NO (top) and AD and NO (bottom) subjects in 2 dimensional plot using z-scores from a single hip-
pocampus voxel GMV and total gray matter volume respectively. Additional contours show predictive probabilities obtained by post hoc Gaussian process classiﬁcation of the clinical vs.
normal subjects using a squared exponential covariance and cumulative Gaussian likelihood function.Middle column shows receiver operating characteristic (ROC) curves of classiﬁcation
of pMCI vs. NO (top) and AD vs. NO (bottom) using a 2D Gaussian process classiﬁcation with leave one out cross-validation. Colors indicate 2D classiﬁcation based on local gray matter
volume with tgmv (red), twmv (blue), and tcsf (green) respectively. The right column shows the same group classiﬁcation based on 1d Gaussian process classiﬁcation of uncorrected
t-values (red), t-values after age correction using general linear model (GLM) (blue), and t-values after GLM based correction of all covariate effects.
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mantle (Viviani et al., 2007).We observed that stronger smoothing con-
sistently reduced the local and the whole brain average GPmodel noise
variance. The noise level has a substantial contribution to the variance of
the predictive distribution. Thereby, predicting local gray matter vol-
ume in single subjects of the ADNI test data, we observed that stronger
smoothing reduced uncertainty. Note, by using z-scores of the predic-
tive distribution to obtain the NPMs, the uncertainty differences are
expected to affect the sensitivity to detect local abnormalities. For in-
stance, larger absolute gray matter reductions would be necessary to
produce the same z-score reductions (in the NPM) within two voxels
with high compared to low predictive uncertainty. Although this
might introduce differences in the NPMs across different voxels, this is
a desired behavior of the model and renders inferences about local
gray matter volumes more valid. Regarding the question of a sufﬁcient
adult control sample size for valid predictions in test subjects, we
observed more consistent hyperparameters and latent variableestimates by training with larger subsamples of our database. Similar
to parametric models, larger random training subsamples were also
found to better capture potential late-life nonlinearities and accelerated
structural decline (Fjell et al., 2012; Ziegler et al., 2012b), which then af-
fordsmore speciﬁc predictions in subjects at risk for developing demen-
tia. Note, that using the presented covariance kernel forms an
information bottleneck that compresses individual differences in the co-
variate space to one kernel matrix for subsequent predictions. Conse-
quently, using larger training samples also results in more densely
sampled covariate spaces which affordmore precise individualized pre-
dictions. Inspecting test subjects' hippocampus predictions using a
training database of increasing size, we found a rather constant average
uncertainty of predictions but substantially reducedﬂuctuationof preci-
sion across individual test subjects. According to this analysis, a larger
sample size favors a higher stability of the predictive uncertainty
which is expected to result in a more constant sensitivity to detect
brain abnormalities across different individuals, e.g. with different
Fig. 9.Model components and Normative Probability Maps (NPMs) for 3 NO and 3 AD subjects from the ADNI testing sample in coronal slice and 12 mm full width at half maximum
(FWHM) data. Individual ADNI rids, age, sex, total gray matter volume (ml) and total intracranial volume (ml) are given. Descending rows show the prediction by the GP model, the
observed local gray matter volumes, prediction errors (i.e. observed–expected values), the square root of predictive uncertainty and NPMs (i.e. local z-maps).
345G. Ziegler et al. / NeuroImage 97 (2014) 333–348ages, brain sizes, etc. Note, however, that due to the domination of the
noise term in the predictive uncertainty, the effects of different degrees
of smoothing and variability across the corticalmantle, is expected to be
more substantial than ﬂuctuations due to individual differences in very
large samples.
Some caveats and directions for development of the presented
approach have to be mentioned. Firstly, structural brain aging is ex-
pected to be a highly individual process embedded in a complex and
reciprocally interacting system including the genes, physiology, be-
havior, and the individual cultural environment (Baltes et al., 2006;
Jagust, 2009). We assume that this process becomes manifest in the
individual brain trajectories forming a ﬂowﬁeld of lifespan brain de-
velopment after accounting for subject's covariates. This is in line
with recent evidence from mixed-effects analysis of repeated mea-
sures MRI, showing substantial individual differences of regional
structural trajectories (Raz et al., 2010). Thereby, deﬁning a sufﬁ-
cient normative reference for pathological structural aging, one nec-
essarily requires an approximation of the structure of the ﬂowﬁeld
including the most common individual differences. Apart from po-
tential secular trends and cohort effects of a purely cross-sectional
design (for a more detailed discussion of this point see Ziegler
et al., 2012a) we here make the strong assumption that the hiddencauses of individual differences in elderly are fully captured by the
above considered covariate space D . As recently pointed out by
Doyle et al. (2013b), personalized modeling approaches are required
in order to make personalized medicine reality. We might speculate
that using a sufﬁciently high-dimensional multivariate parametriza-
tion of individual differences including genes, education, cognitive
scores (see e.g. Ziegler et al., 2013), and behavior, the considered
cross-sectional trajectory estimates might converge to estimates
from repeated measures MRI design. Otherwise, combining cross-
sectional with high quality longitudinal segmentations (Jovicich
et al., 2013, see e.g.) might further improve model-based predictions
and inference.
Secondly, a limitation of this study is the potential adverse effects
of pooling across MRI scanners and sequences (Jovicich et al., 2013,
see e.g.). However, the purpose of the proposed database-based pre-
diction and inference in elderly subjects is to aim at generalization to
new clinical scanners while exploiting the beneﬁts of a large healthy
aging reference sample and the diverse appearance of normal aging.
In this particular model, local and global scanner effects are expected
to be captured by increases of the model error variance. Within the
Bayesian inference framework, we expect this to result in reduced
predictive conﬁdence for particular brain regions with expectable
346 G. Ziegler et al. / NeuroImage 97 (2014) 333–348high scanner related artifacts, e.g. in subcortical regions. The pro-
posed z-scores account for this local increase of uncertainty in
terms of higher deviation from normality to be required to observe
the same z-score. Thus, the gains of generalization to new clinical
scanners come at the cost of a reduced sensitivity for gray matter ab-
normality detection. Notably, an alternative model accounting for all
site effects is likely to result in biased conclusions in predictions on
new scanners due to severe overconﬁdence. We argue that the pro-
vided comparisons of GP-based z-scores in clinical groups still dem-
onstrate a potentially useful characterization of unseen subjects
from new scanners. Future studies might focus on generalizable as-
sumptions about forms of scanner related variability which could
be included in model training and inform predictions on scanners
with speciﬁc imaging parameters.
Thirdly, a serious problem with GP methods is that it requires
computation which grows as O(n3), where n is the number of sub-
jects. This is computationally expensive, especially if we aim at the
advantages of large sample healthy aging databases. Future studies
might explore sparse approximation techniques (Quiñonero-Candela
and Rasmussen, 2005; Quinonero-Candela et al., 2007) for more effec-
tive local models or spatial regularization (see e.g. Banerjee et al.,
2008; Sang and Huang, 2012).
Finally, the local brain morphology in our GP models was restricted
to graymatter segments obtained fromVBM. Althoughmedial temporal
lobe atrophy is one of the most-established imaging biomarkers for AD
(Frisoni et al., 2010; Teipel et al., 2013), our GP frameworkmight be ex-
tended to other potential disease sensitive sequences and modalities,
e.g. local white matter hyperintensities (Brickman et al., 2012;
Carmichael et al., 2010) or [18F]ﬂuorodeoxyglucose Positron Emission
Tomography (FDG-PET) (Dukart et al., 2013) as well as amyloid PET
(Quigley et al., 2011).
Conclusion
We argue, that decisions about subjects at risk to convert to path-
ological agingmight be supported via transparent evidence given the
quantitative models of normal and pathological aging. Normative
probability maps and global brain volume z-scores afford individual-
ized detection of abnormalities and appropriately account for the
uncertainty of the model and the model's predictions due to random
inﬂuences, e.g. noisy observations and sampling.
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